Esperion Therapeutics
ESPR
ESPR
167 hedge funds and large institutions have $1.32B invested in Esperion Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2.85% more ownership
Funds ownership: 102.83% → 105.68% (+2.8%)
2% more funds holding
Funds holding: 163 → 167 (+4)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
167
Holding in Top 10
3
Calls
$42.3M
Puts
$22.8M
Top Buyers
| 1 | +$166M | |
| 2 | +$22.8M | |
| 3 | +$17.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.53M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$9.34M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$17.6M | |
| 3 | -$14.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.99M |
| 5 |
SIM
Spark Investment Management
New York
|
-$6.34M |